An Old New Friend: Folliculo-Stellate Cells in Pituitary Neuroendocrine Tumors
- PMID: 40643539
- PMCID: PMC12248583
- DOI: 10.3390/cells14131019
An Old New Friend: Folliculo-Stellate Cells in Pituitary Neuroendocrine Tumors
Abstract
Pituitary neuroendocrine tumors (PitNETs) represent a complex pathology based on numerous incompletely elucidated molecular mechanisms. Beyond tumor cells, analyzing the tumor microenvironment may help identify novel prognostic markers and therapies. A key component of this environment is the folliculo-stellate (FS) cell. We examined FS cells in 77 PitNETs obtained by transsphenoidal surgery, using glial fibrillary acidic protein (GFAP) as an immunohistochemical marker. Immunohistochemistry for anterior pituitary hormones and transcription factors was performed to accurately classify the tumors. Our study included 19 somatotroph, 16 mammosomatotroph, 5 plurihormonal PIT-1 positive, 7 corticotroph, 14 gonadotroph, 11 unusual plurihormonal, and 5 null cell PitNETs. FS cells were observed in 55 of the cases, distributed isolated, in small groups or diffuse networks. A considerable number of tumors immunopositive for more than one hormone (including associations between GH/PRL, but also unusual combinations like GH/ACTH) also contained FS cells (p < 0.01), suggesting their involvement in tumor lineages differentiation. In 27 tumors, GFAP-positive cells clustered in highly vascularized areas. Additionally, in 11 of these cases a direct interaction between endothelial cells and FS cells was noted, sustaining their potential role in tumor angiogenesis. Given their complexity, FS cells may be crucial for understanding tumorigenesis mechanisms.
Keywords: FS cells; GFAP; PitNETs; blood vessels.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
PIT-1/SF-1-positive pituitary tumors in patients with acromegaly: transcriptomic perspective.Acta Neuropathol Commun. 2025 Aug 14;13(1):174. doi: 10.1186/s40478-025-02091-z. Acta Neuropathol Commun. 2025. PMID: 40813692 Free PMC article.
-
The Roles of PD-L1, Ki-67, P53, and Cyclin D1 in PitNETs: Diagnostic and Prognostic Implications in a Series of 74 Patients.Int J Mol Sci. 2025 Aug 13;26(16):7830. doi: 10.3390/ijms26167830. Int J Mol Sci. 2025. PMID: 40869149 Free PMC article.
-
E-cadherin expression and gene expression profiles in corticotroph pituitary neuroendocrine tumor subtypes.J Neuropathol Exp Neurol. 2024 Jun 20;83(7):586-595. doi: 10.1093/jnen/nlae034. J Neuropathol Exp Neurol. 2024. PMID: 38777808
-
Surgical and non-surgical interventions for primary and salvage treatment of growth hormone-secreting pituitary adenomas in adults.Cochrane Database Syst Rev. 2024 Feb 6;2(2):CD013561. doi: 10.1002/14651858.CD013561.pub2. Cochrane Database Syst Rev. 2024. PMID: 38318883 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
References
-
- Lloyd R.V., Osamura R.Y., Klöppel G., Rosai J., editors. WHO Classification of Tumours of Endocrine Organs. 4th ed. International Agency for Research on Cancer IARC; Lyon, France: 2017. print.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous